The Role of Childhood Sexual Abuse (CSA) in Adult Cognitive Behaviour Therapy

2007 ◽  
Vol 35 (4) ◽  
pp. 447-455 ◽  
Author(s):  
Michael Linden ◽  
Ahmes Zehner

Sexual abuse in childhood is a pathogenetic factor for psychological disorders. The attention given to this phenomenon varies between therapists and therapeutic schools. The question is how often sexual abuse is recognized as a problem in cognitive behaviour therapy and how this is related to the present symptoms and therapeutic problems. 1223 case reports, written as application for reimbursement of routine cognitive behaviour therapy, were submitted to a content analysis in respect to childhood sexual abuse. Sexual abuse was mentioned in 10.3% of the cases; 59% of female and 50.0% of male victims were abused by relatives. Sexually abused patients showed significantly increased rates of inadequate care and negative life events during childhood. In comparison to controls, cases showed significantly increased rates of “eating disorders” (15 vs. 6; p<.05), “substance abuse/addiction” (16 vs. 6; p<.05), “suicide attempts” (15 vs. 3; p<.01), “strict refusal of sexual partners” (15 vs. 5; p<.05), “frequently changing partners” (21 vs. 3; p<.001), “problems in marriage/partnership” (95 vs. 77; p<.05) and “sexual problems” (51 vs. 24; p<.001). Childhood sexual abuse is a problem, frequently seen in behaviour therapy patients and therefore also warranting special attention in routine patient care. Sexual abuse is understood by cognitive behaviour therapists as an indicator for traumatizing conditions in general during childhood. It is associated with specific treatment problems and therapeutic needs in adulthood.

2013 ◽  
Vol 30 (2) ◽  
pp. 74-83 ◽  
Author(s):  
Jannette M. Parr ◽  
David J. Kavanagh ◽  
Ross McD. Young ◽  
Barbara Stubbs ◽  
Nick Bradizza

Benzodiazepines are widely prescribed to manage sleep disorders, anxiety and muscular tension. While providing short-term relief, continued use induces tolerance and withdrawal, and in older users, increases the risk of falls. However, long-term prescription remains common, and effective interventions are not widely available. This study developed a self-managed cognitive behaviour therapy package for cessation of benzodiazepine use delivered to participants via mail (M-CBT) and trialled its effectiveness as an adjunct to a general practitioner (GP)-managed dose reduction schedule. In the pilot trial, participants were randomly assigned to GP management with immediate or delayed M-CBT. Significant recruitment and engagement problems were experienced, and only three participants were allocated to each condition. After immediate M-CBT, two participants ceased use, while none receiving delayed treatment reduced daily intake by more than 50%. Across the sample, doses at 12 months remained significantly lower than baseline, and qualitative feedback from participants was positive. While M-CBT may have promise, improved engagement of GPs and participants is needed for this approach to substantially impact on community-wide benzodiazepine use.


Sign in / Sign up

Export Citation Format

Share Document